Case number 3:18-cv-13695
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. SOLARIS PHARMA CORP. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 15, 2019 | 17 | Order of Dismissal (3) Docket Text: Stipulation and Order of Voluntary Dismissal without prejudice. Signed by Judge Peter G. Sheridan on 4/15/2019. (mmh) |
| Apr 12, 2019 | 16 | Main Document (1) Docket Text: Letter from William P. Deni, Jr. to the Honorable Peter G. Sheridan, U.S.D.J. re: Stipulated Voluntary Dismissal Without Prejudice. (Attachments: # (1) Proposed Stipulated Voluntary Dismissal Without Prejudice)(DENI, WILLIAM) |
| Apr 12, 2019 | 16 | Proposed Stipulated Voluntary Dismissal Without Prejudice (3) |
| Apr 12, 2019 | 16 | Letter (1) |
| Mar 21, 2019 | N/A | Pretrial Conference - Initial (0) Docket Text: Text Minute Entry for proceedings held before Magistrate Judge Lois H. Goodman: Initial Pretrial Conference held on 3/21/2019 via Conference Call. (if, ) |
| Mar 5, 2019 | 15 | Answer to Counterclaim (17) |
| Mar 5, 2019 | 15 | Main Document (17) Docket Text: ANSWER to Counterclaim by DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC. (Attachments: # (1) Certificate of Service)(DENI, WILLIAM) |
| Mar 5, 2019 | 15 | Certificate of Service (2) |
| Feb 22, 2019 | 14 | Order (5) Docket Text: ORDER SCHEDULING CONFERENCE. Scheduling Conference set for 3/21/2019 10:00 AM in Trenton - Courtroom 7E before Magistrate Judge Lois H. Goodman. Signed by Magistrate Judge Lois H. Goodman on 2/22/2019. (mmh) |
| Feb 20, 2019 | N/A | Update Answer Due Deadline (0) Docket Text: Clerk`s Text Order - The document [13] Application for Clerk's Order to Ext Answer/Proposed Order, submitted by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, VALEANT PHARMACEUTICALS IRELAND LTD., KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC. has been GRANTED. The answer due date has been set for 3/5/2019. (mmh) |
| Feb 19, 2019 | 13 | Application for Clerk's Order to Ext Answer/Proposed Order (2) Docket Text: Application and Proposed Order for Clerk's Order to extend time to answer as to Plaintiffs Valeant Pharmaceuticals North America LLC, Valeant Pharmaceuticals Ireland Ltd., Dow Pharmaceutical Sciences, Inc., and Kaken Pharmaceutical Co., Ltd... (DENI, WILLIAM) |
| Jan 28, 2019 | 12 | Corporate Disclosure Statement (aty) (3) Docket Text: Corporate Disclosure Statement by SOLARIS PHARMA CORP.. (RICHTER, JAMES) |
| Jan 28, 2019 | 11 | Answer to Complaint (30) Docket Text: ANSWER to Complaint , Affirmative Defenses and, COUNTERCLAIM against All Plaintiffs by SOLARIS PHARMA CORP..(RICHTER, JAMES) |
| Jan 11, 2019 | 10 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by JAMES S. RICHTER on behalf of SOLARIS PHARMA CORP. (RICHTER, JAMES) |
| Dec 6, 2018 | 9 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by JUSTIN JAMES HASFORD on behalf of KAKEN PHARMACEUTICAL CO., LTD. (HASFORD, JUSTIN) |
| Dec 5, 2018 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. SOLARIS PHARMA CORP. waiver sent on 11/28/2018, answer due 1/28/2019. (LOWER, J.) |
| Dec 5, 2018 | 7 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by J. BRUGH LOWER on behalf of DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC (LOWER, J.) |
| Sep 10, 2018 | N/A | Add and Terminate Judges (0) Docket Text: Judge Peter G. Sheridan and Magistrate Judge Lois H. Goodman added. (kas, ) |
| Sep 10, 2018 | 4 | Summons Issued (2) Docket Text: SUMMONS ISSUED as to SOLARIS PHARMA CORP.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (kas, ) |
| Sep 10, 2018 | 5 | AO120 Patent/Trademark Form (1) Docket Text: AO120 Patent Form filed. (kas, ) |
| Sep 10, 2018 | 6 | AO120 Patent/Trademark Form (1) Docket Text: AO120 Patent Form filed. (kas, ) |
| Sep 7, 2018 | 1 | Complaint (23) |
| Sep 7, 2018 | 3 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by KAKEN PHARMACEUTICAL CO., LTD.. (DENI, WILLIAM) |
| Sep 7, 2018 | 2 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC identifying Bausch Health Companies Inc. as Corporate Parent.. (DENI, WILLIAM) |
| Sep 7, 2018 | 1 | L. Civ. R. 11.2 Certification (2) |
| Sep 7, 2018 | 1 | Civil Cover Sheet (1) |
| Sep 7, 2018 | 1 | Exhibit H (11) |
| Sep 7, 2018 | 1 | Exhibit G (17) |
| Sep 7, 2018 | 1 | Exhibit F (14) |
| Sep 7, 2018 | 1 | Exhibit E (11) |
| Sep 7, 2018 | 1 | Exhibit D (17) |
| Sep 7, 2018 | 1 | Exhibit C (17) |
| Sep 7, 2018 | 1 | Main Document (23) Docket Text: COMPLAINT against SOLARIS PHARMA CORP. ( Filing and Admin fee $ 400 receipt number 0312-9009316), filed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Civil Cover Sheet, # (10) L. Civ. R. 11.2 Certification)(DENI, WILLIAM) |
| Sep 7, 2018 | 1 | Exhibit B (16) |
| Sep 7, 2018 | 1 | Exhibit A (15) |
| Sep 7, 2018 | 1 | Complaint* (1) |
